📰 Source: sciencedaily | Latest Science News – ScienceDaily
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.
This post was automatically imported by OratioRepostBot.
You must log in or # to comment.